Schedule 13D ownership disclosure

LANTERN PHARMA INC

Security class unavailable · CUSIP: 51654W101

Event date: 2020-06-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-015494
Form type
SC 13D
Filer
BIOLOGICAL MIMETICS INC
CIK
CIK 1052423
Filed
Jun 23, 2020
Reporting period
Jun 15, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub